Ownes & Minor (OMI) Tops Q1 EPS by 1c, reaffirms guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
- AMD shares fall amid AI chip sector selloff
- JetBlue shares fall amid American results, fuel cost concerns
- Bloom Energy Corp. (BE) Tops Q3 EPS by 25c, Beats on Revenue; Offers FY26 Guidance
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- LKQ posts Q3 loss, replaces CEO amid Europe struggles
Owens & Minor (OMI) PT Lowered to $18 at BofA Securities
May 6, 2024 5:52 AM EDTBofA Securities analyst Michael Cherny lowered the price target on Owens & Minor (NYSE: OMI) to $18.00 (from $19.00) while maintaining a Underperform rating.
The analyst comments "OMIs Products and Healthcare Services (P&HS) saw growth accelerate in 1Q, likely driven by utilization. However, in the more important Patient Direct (PD) business, growth decelerated, and margins compressed due to investments. While... More



